Ikena Oncology ^Investors

Ikena Oncology is an innovative biotechnology company based in Boston, Massachusetts, founded in 2016 The company is focused on developing precision medicines for cancer patients by targeting specific genetic and epigenetic drivers of tumors Ikena has successfully raised significant funding, with an investment scale of approximately $125 million to support its research and development efforts The company aims to advance its proprietary drug candidates into clinical trials, contributing to the evolving landscape of cancer therapeutics Ikena Oncology is committed to improving patient outcomes through targeted therapies and personalized treatment approaches